These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32331283)

  • 21. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new macrolide antibiotics. Azithromycin and clarithromycin.
    Stein GE; Havlichek DH
    Postgrad Med; 1992 Jul; 92(1):269-72, 277-82. PubMed ID: 1319579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
    Ito K; Ogihara K; Kanamitsu S; Itoh T
    Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
    Berghaus LJ; Giguère S; Guldbech K
    Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrolide antibiotics.
    Pallasch TJ
    Dent Today; 1997 Nov; 16(11):72, 74-5, 78-9. PubMed ID: 9560736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes Following Macrolide Use in Kidney Transplant Recipients.
    Jeong R; Quinn RR; Lentine KL; Lloyd A; Ravani P; Hemmelgarn B; Braam B; Garg AX; Wen K; Wong-Chan A; Gourishankar S; Lam NN
    Can J Kidney Health Dis; 2019; 6():2054358119830706. PubMed ID: 30815270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choosing the right macrolide antibiotic. A guide to selection.
    Charles L; Segreti J
    Drugs; 1997 Mar; 53(3):349-57. PubMed ID: 9074839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data.
    Carbon C; Poole MD
    J Chemother; 1999 Apr; 11(2):107-18. PubMed ID: 10326741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of macrolide use in pediatrics.
    Klein JO
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats].
    Yoshida H; Furuta T
    Jpn J Antibiot; 1999 Jul; 52(7):497-503. PubMed ID: 10516929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
    Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.